Sign in

You're signed outSign in or to get full access.

John D. Gordan, III

About John D. Gordan, III

Independent director of General American Investors Company, Inc. since 1986; age 79; Harvard University A.B. and Harvard Law School J.D.; retired Senior Counsel (and former Partner) at Morgan Lewis & Bockius LLP focused on civil litigation and insurance, with prior service as Assistant U.S. Attorney (SDNY) . All directors other than the CEO are independent, and the Board regularly holds executive sessions chaired by independent directors . Tenure and legal expertise suggest deep governance familiarity and risk oversight capability .

Past Roles

OrganizationRoleTenureCommittees/Impact
Morgan Lewis & Bockius LLPSenior Counsel (retired June 2011); previously Partner for 16 yearsThrough June 2011Civil litigation focus; insurance industry specialization
Beazley USA Services, Inc.Attorney2013–2019Legal practice; insurance sector exposure
Lord Day & Lord, Barrett SmithPartnerPrior to Morgan LewisLitigation experience
U.S. Attorney’s Office, SDNYAssistant U.S. Attorney1971–1976Federal prosecutorial experience

External Roles

OrganizationRoleTenureNotes
Arbitrator (unspecified affiliation)Arbitrator2013–2019Arbitration experience alongside legal practice
Public company boardsNoneNo public company directorships

Board Governance

  • Committee assignments and chair roles:
    • Audit Committee: Chairman; committee met 4x in 2024 (Jan 24, Feb 16, Jul 24, Dec 4) and once post-year (Feb 12, 2025); committee members are NYSE “independent” .
    • Executive Committee: Chairman alongside Spencer Davidson; did not meet in 2024 .
    • Nominating Committee: Member; met once in 2024 (Jan 24) and once post-year (Feb 12, 2025) .
    • Pension Committee: Member; met once in 2024 (Jan 24) and once post-year (Feb 12, 2025) .
  • Independence and attendance:
    • Independent director status affirmed; all committees are chaired by independent directors .
    • Board held eight meetings in 2024; each Director attended at least 75% of Board and committee meetings; all Directors participated in the 2024 annual meeting (Apr 8, 2024) .
  • Structure and oversight:
    • Board oversight covers investment, administration, valuation, and compliance risks; independent sessions occur regularly .

Fixed Compensation

ComponentAmountBasisYear
Annual Retainer (non-officer directors)$30,000Fixed cash retainer2024
Meeting Fees$1,250 per meetingBoard and committee meetings2024
Aggregate Compensation (John D. Gordan, III)$47,500Total director fees earned2024
Pension/Retirement Benefits (director)Not applicable to directors2024

Note: In 2024, the Board met 8 times; Audit met 4; Nominating 1; Pension 1; Executive 0 . Fees are paid per meeting attended .

Performance Compensation

Performance ComponentMetricsVestingAmount
None disclosed for directors

Other Directorships & Interlocks

Company/EntityRoleOverlap/Interlock Risk
Public company directorshipsNoneNone disclosed

Expertise & Qualifications

  • Extensive legal expertise in civil litigation and insurance; former Assistant U.S. Attorney (SDNY) .
  • Harvard A.B. and Harvard J.D.; long-standing board service since 1986 .
  • Chairs Audit Committee and co-chairs Executive Committee; risk oversight experience within Board’s structure .

Equity Ownership

Title of ClassShares Beneficially OwnedPercent of ClassNotes
Common Stock277,2761.18%Includes 253,507 shares with shared voting/dispositive power; includes 5,085 shares owned by spouse in IRA, disclaimed
5.95% Cumulative Preferred Stock, Series B1,0000.01%
Dollar Range of Equity Securities (Director)Over $100,000As of Dec 31, 2024

Governance Assessment

  • Strengths:

    • Independent director with deep legal and insurance sector expertise; chairs Audit Committee and co-chairs Executive Committee, enhancing oversight continuity .
    • Material personal ownership (1.18% of common) aligns interests with shareholders; over $100,000 dollar-range disclosed .
    • Board and committee processes are formalized; executive sessions held regularly; all directors participated in the 2024 annual meeting .
  • Risks and RED FLAGS:

    • Audit Committee has no designated “audit committee financial expert,” which may be viewed as a governance deficiency by some investors despite members’ asserted financial expertise .
    • Very long tenure (director since 1986) can raise independence and refreshment concerns among governance-focused investors, even though independence is affirmed by the Board .
    • Director compensation appears entirely cash-based (retainer + meeting fees) with no disclosed equity grants to directors, potentially reducing formal pay-for-performance linkage, though personal share ownership provides alignment .
  • Attendance/engagement:

    • Board met eight times; each Director met at least the 75% attendance threshold; committee meeting cadence indicates active oversight (Audit 4x; Nominating/Pension 1x each) .